BAYNN Stock Chart & Stats
$779.00
$0.00(0.00%)
At close: 4:00 PM EDT
$779.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$430.63 - $1,050.00
Previous CloseN/A
Volume2.00
Average Volume (3M)0.00
Market Cap
$936.06B
Enterprise Value$71.97K
Total Cash (Recent Filing)$6.66B
Total Debt (Recent Filing)$38.89B
Price to Earnings (P/E)―
Beta0.32
Next Earnings
Aug 04, 2026EPS Estimate
15.36Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)-2.19
Shares Outstanding982,424,100
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)1.40
Price to Sales (P/S)0.80
P/FCF Ratio17.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,094.55Price Target Upside40.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)87.1
Revenue Forecast (FY)$908.56B
Bulls Say, Bears Say
Bulls Say
Profitability MarginsSustained high gross and mid-teens operating margins indicate strong pricing power and efficient product mix across businesses. Those margins provide structural capacity to fund R&D, commercial investment and absorb cyclical shocks, supporting long‑term earnings potential.
Cash GenerationConsistent positive operating and free cash flow provides durable internal funding for capex, R&D, dividends and liabilities. Even with weaker momentum, multi‑billion FCF gives flexibility to service debt and finance strategic investments without sole reliance on external financing.
Diversified Life‑sciences FranchiseA diversified business model across pharmaceuticals and crop science spreads revenue exposure across healthcare and agriculture cycles, supports multiple innovation pipelines, and reduces single‑market dependency, enhancing resilience and long‑term cashflow stability.
Bears Say
Multi‑year Net LossesRecurring net losses over multiple years weaken retained earnings and investor returns, constrain ROE and undermine confidence in sustained profitability. Persistent losses make rebuilding capital buffers and funding strategic initiatives more challenging without asset sales or higher leverage.
Declining Revenue TrendNegative topline momentum erodes operating leverage and makes margin preservation harder over time. Declining sales can reflect competitive pressure, patent cliffs or structural demand shifts, reducing ability to scale fixed costs and fund long‑term R&D and growth initiatives.
High LeverageA levered balance sheet with debt above equity increases sensitivity to earnings volatility and limits strategic optionality. With operating cash covering a small fraction of total debt, deleveraging capacity is constrained, raising refinancing and interest‑rate exposure over the medium term.
Bayer News
BAYNN FAQ
What was Bayer’s price range in the past 12 months?
Bayer lowest stock price was $430.63 and its highest was $1050.00 in the past 12 months.
What is Bayer’s market cap?
Bayer’s market cap is $936.06B.
When is Bayer’s upcoming earnings report date?
Bayer’s upcoming earnings report date is Aug 04, 2026 which is in 3 days.
How were Bayer’s earnings last quarter?
Bayer released its earnings results on May 12, 2026. The company reported $54.144 earnings per share for the quarter, beating the consensus estimate of $46.192 by $7.952.
Is Bayer overvalued?
According to Wall Street analysts Bayer’s price is currently Undervalued.
Does Bayer pay dividends?
Bayer pays a Annually dividend of $2.186 which represents an annual dividend yield of 0.24%. See more information on Bayer dividends here
What is Bayer’s EPS estimate?
Bayer’s EPS estimate is 15.36.
How many shares outstanding does Bayer have?
Bayer has 982,424,100 shares outstanding.
What happened to Bayer’s price movement after its last earnings report?
Bayer reported an EPS of $54.144 in its last earnings report, beating expectations of $46.192. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Bayer?
Currently, no hedge funds are holding shares in MX:BAYNN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Bayer Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$1,094.55 (40.51% Upside)
$1,094.55 (40.51% Upside)
Blogger Sentiment
Bullish
MX:BAYNN Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth €2.9M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
70.33%
12-Months-Change
Fundamentals
Return on Equity
0.24%
Trailing 12-Months
Asset Growth
-1.13%
Trailing 12-Months
Company Description
Bayer
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
BAYNN Stock 12 Month Forecast
Average Price Target
$1,094.55
▲(40.51% Upside)